Target intelligence / Profile preview

Microwave thermal ablation of soft tissue (MWA)

Target: MWA

Overview

Microwave thermal ablation of soft tissue is a clinical treatment procedure, not a therapeutic target molecule or receptor. It is a minimally invasive, image-guided technique that uses microwave energy to generate heat and destroy tumor cells through thermal coagulation and localized tissue necrosis. The procedure involves inserting a microwave antenna directly into a tumor, where electromagnetic energy at frequencies of 915 MHz or 2.45 GHz causes water molecule rotation and creates heat. This technique is a physical/thermal intervention, not a molecular entity that can be modulated by therapeutic drugs.

Other names: Microwave ablation

Beyond the preview

Go deeper on Microwave thermal ablation of soft tissue (MWA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microwave thermal ablation of soft tissue (MWA).

Explore the full profile